Latest News of ARWR
The past three years for Arrowhead Pharmaceuticals (NASDAQ:ARWR) investors has not been profitable
By Yahoo! Finance |
4 months ago
Arrowhead Pharmaceuticals' stock price has risen 13% in the last month, offering relief after a 59% drop over three years. Revenue growth of 9.6% annually contrasts with declining share prices, making...